Actualités Hemagen Diagnostics Inc (CE) - HMGN | Actions OTCMarkets

Outils de qualité professionnelle, pour des investisseurs individuels.

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION REQUIRED IN PROXY STATEMENT...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Amended tender offer statement by Issuer (SC TO-I/A)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO AMENDMENT NO. 1 (Rule 14d-100) ...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or...

Hemagen Successfully Completes Its Offer to Exchange 8% Senior Subordinated Secured Convertible Notes Due September 30, 2009

William P. Hales, Chairman, President and CEO, of Hemagen Diagnostics, Inc., (OTCBB: HMGN) (the “Company”) today announced the...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Hemagen Diagnostics Inc (CE) (HMGN)

Outils de qualité professionnelle, pour des investisseurs individuels.

HMGN Actualités

- Statement of Changes in Beneficial Ownership (4)

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

- Current report filing (8-K)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Amended tender offer statement by Issuer (SC TO-I/A)

- Current report filing (8-K)

Hemagen Successfully Completes Its Offer to Exchange 8% Senior Subordinated Secured Convertible Notes Due September 30, 2009

- Securities Registration: Employee Benefit Plan (S-8)

- Current report filing (8-K)

- Tender offer statement by Issuer (SC TO-I)

- Quarterly Report (10-Q)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Hemagen Diagnostics Inc (CE) (HMGN) Actualités

Hemagen Diagnostics Inc (CE) (HMGN)

Outils de qualité professionnelle, pour des investisseurs individuels.

HMGN Actualités

- Statement of Changes in Beneficial Ownership (4)

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

- Current report filing (8-K)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Amended tender offer statement by Issuer (SC TO-I/A)

- Current report filing (8-K)

Hemagen Successfully Completes Its Offer to Exchange 8% Senior Subordinated Secured Convertible Notes Due September 30, 2009

- Securities Registration: Employee Benefit Plan (S-8)

- Current report filing (8-K)

- Tender offer statement by Issuer (SC TO-I)

- Quarterly Report (10-Q)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application